Literature DB >> 16507783

Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha.

Jianguo Li1, Marta Bosch-Marce, Ashika Nanayakkara, Vladimir Savransky, Susan K Fried, Gregg L Semenza, Vsevolod Y Polotsky.   

Abstract

We have previously shown that exposure of C57BL/6J mice to intermittent hypoxia (IH) leads to 1) hypertriglyceridemia due to upregulation of pathways of lipid biosynthesis, including sterol regulatory element binding protein (SREBP)-1 and stearoyl CoA desaturase (SCD)-1; and 2) hypercholesterolemia due to impaired cholesterol uptake. The goal of the present study was to examine whether hypoxia-inducible factor (HIF)-1 is implicated in changes in lipid metabolism induced by IH. Lean HIF-1alpha (Hif1a)(+/-) mice, which are heterozygous for a null allele at the locus encoding the HIF-1alpha subunit, and their wild-type (WT) Hif1a(+/+) littermates were exposed to IH or control conditions for 5 days. IH increased fasting blood glucose, serum total cholesterol, and high-density lipoprotein-cholesterol, phospholipids, triglycerides (TG), and leptin in mice of both genotypes, whereas serum insulin and interleukin-6 were elevated only in WT mice. The impact of IH on serum TG levels in WT mice was significantly greater than that in Hif1a(+/-) mice (95 +/- 9 vs. 66 +/- 6 mg/dl, P < 0.05), whereas cholesterol and glucose levels were affected independently of genotype. Under hypoxic conditions, mRNA and protein levels of SREBP cleavage-activating protein (SCAP) and SCD-1 and protein levels of nuclear isoform of SREBP-1 in the liver were induced to significantly higher levels in WT mice than in Hif1a(+/-) mice. We conclude that 1) the effect of IH on serum TG levels is mediated through HIF-1, 2) HIF-1 may impact on posttranscriptional regulation of SREBP-1, and 3) the effect of IH on serum cholesterol levels was not altered by partial HIF-1alpha deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507783     DOI: 10.1152/physiolgenomics.00293.2005

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  66 in total

1.  Metabolic insight into mechanisms of high-altitude adaptation in Tibetans.

Authors:  Ri-Li Ge; Tatum S Simonson; Robert C Cooksey; Uran Tanna; Ga Qin; Chad D Huff; David J Witherspoon; Jinchuan Xing; Bai Zhengzhong; Josef T Prchal; Lynn B Jorde; Donald A McClain
Journal:  Mol Genet Metab       Date:  2012-03-17       Impact factor: 4.797

Review 2.  Metabolic changes through hypoxia in humans and in yeast as a comparable cell model.

Authors:  Nikolaus C Netzer; Michael Breitenbach
Journal:  Sleep Breath       Date:  2010-06-10       Impact factor: 2.816

Review 3.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

4.  SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  Sleep Med Clin       Date:  2007-06

5.  Proteomic analysis of mitochondrial proteins in cardiomyocytes from rats subjected to intermittent hypoxia.

Authors:  Wei-Zhong Zhu; Xiu-Feng Wu; Yi Zhang; Zhao-Nian Zhou
Journal:  Eur J Appl Physiol       Date:  2011-07-07       Impact factor: 3.078

Review 6.  Obstructive Sleep Apnoea and Type 2 Diabetes.

Authors:  Abd A Tahrani; Asad Ali
Journal:  Eur Endocrinol       Date:  2014-02-28

7.  Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes.

Authors:  Christian Reinke; Shannon Bevans-Fonti; Luciano F Drager; Mi-Kyung Shin; Vsevolod Y Polotsky
Journal:  J Appl Physiol (1985)       Date:  2011-07-07

Review 8.  Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism.

Authors:  Ajibola Monsur Adedayo; Oladipupo Olafiranye; David Smith; Alethea Hill; Ferdinand Zizi; Clinton Brown; Girardin Jean-Louis
Journal:  Sleep Breath       Date:  2012-08-18       Impact factor: 2.816

9.  Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation.

Authors:  H Zhang; D H Fagan; X Zeng; K T Freeman; D Sachdev; D Yee
Journal:  Oncogene       Date:  2010-02-15       Impact factor: 9.867

10.  Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension.

Authors:  Jesmin Jesmin; Mahbubur Sm Rashid; Hasan Jamil; Raquel Hontecillas; Josep Bassaganya-Riera
Journal:  BMC Med Genomics       Date:  2010-10-13       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.